Direct and indirect effects of cytomegalovirus: can we prevent them?
Razonable
Raymund
R
D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001855:Bone Marrow Diseases / Q000209:etiology / Q000517:prevention & control; D003587:Cytomegalovirus / Q000235:genetics / Q000302:isolation & purification / Q000502:physiology; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000517:prevention & control; D004066:Digestive System Diseases / Q000209:etiology / Q000517:prevention & control; D005334:Fever / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D016867:Immunocompromised Host; D009205:Myocarditis / Q000209:etiology / Q000517:prevention & control; D009393:Nephritis / Q000209:etiology / Q000517:prevention & control; D009894:Opportunistic Infections / Q000209:etiology / Q000517:prevention & control; D016377:Organ Transplantation; D011024:Pneumonia, Viral / Q000209:etiology / Q000517:prevention & control; D016133:Polymerase Chain Reaction; D011183:Postoperative Complications / Q000517:prevention & control* / Q000821:virology; D011292:Premedication; D012307:Risk Factors; D015163:Superinfection / Q000209:etiology / Q000517:prevention & control; D014775:Virus Activation; D014779:Virus Replication
D000998:Antiviral Agents